Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

X4 Pharmaceuticals, Inc. - Common Stock (NQ:XFOR)

2.750 +0.040 (+1.48%)
Streaming Delayed Price Updated: 3:26 PM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 94,151
Open 2.690
Bid (Size) 2.710 (4)
Ask (Size) 2.760 (2)
Prev. Close 2.710
Today's Range 2.680 - 2.790
52wk Range 2.670 - 33.90
Shares Outstanding 24,851,648
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Breaking Down X4 Pharmaceuticals: 4 Analysts Share Their Views
Via Benzinga

Performance

YTD
-87.8%
-87.8%
1 Month
-51.5%
-51.5%
3 Month
-81.6%
-81.6%
6 Month
-75.1%
-75.1%
1 Year
-89.8%
-89.8%

More News

Read More
Earnings Scheduled For March 25, 2025
Via Benzinga
Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Recap: X4 Pharmaceuticals Q4 Earnings
Via Benzinga
Earnings Scheduled For May 1, 2025
Via Benzinga
Earnings Preview For X4 Pharmaceuticals
Via Benzinga
Top 3 Health Care Stocks That May Rocket Higher In April
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
X4 Pharmaceuticals's Earnings Outlook
Via Benzinga
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
XFOR Stock Earnings: X4 Pharmaceuticals Misses EPS for Q1 2024
Via InvestorPlace
FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
XFOR Stock Earnings: X4 Pharmaceuticals Beats EPS for Q4 2023
Via InvestorPlace
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Earnings Scheduled For March 21, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace

Frequently Asked Questions

Is X4 Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, X4 Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does X4 Pharmaceuticals, Inc. - Common Stock trade on?
X4 Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for X4 Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for X4 Pharmaceuticals, Inc. - Common Stock is XFOR on the Nasdaq Stock Market
What is the current price of X4 Pharmaceuticals, Inc. - Common Stock?
The current price of X4 Pharmaceuticals, Inc. - Common Stock is 2.750
When was X4 Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of X4 Pharmaceuticals, Inc. - Common Stock was at 05/21/25 03:26 PM ET
What is the market capitalization of X4 Pharmaceuticals, Inc. - Common Stock?
The market capitalization of X4 Pharmaceuticals, Inc. - Common Stock is 68.34M
How many shares of X4 Pharmaceuticals, Inc. - Common Stock are outstanding?
X4 Pharmaceuticals, Inc. - Common Stock has 68M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.